ABTC 1202: Phase 1 Study of MK-1775 with Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma and Evaluation of Intratumoral Drug Distribution in Patients with Recurrent Glioblastoma
CTO - IRB 8454
Cancer - Brain
Patients must have a tumor tissue form indicating availability of archived tissue from initial resection at diagnosis of glioblastoma completed and signed by a pathologist. Patients must have a Karnofsky score of greater than or equal to 60%.